HTNV-NP (Hantaan virus nucleoprotein)-specific CTL (cytotoxic T lymphocyte) epitope peptides and application thereof
An epitope peptide and specific technology, which is applied in the field of CTL epitope peptides restricted by HLA-I molecules, can solve the problems of non-specific prevention and treatment methods, and achieve good development and application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0032] The present invention first synthesizes partially overlapping 15 peptides covering the full length of the NP region of the HTNV 76-118 strain, and uses ELISPOT and magnetic bead separation techniques to systematically identify the CD4 on the NP + and CD8 + T cell 15 peptide epitopes, combined with bioinformatics SYFPEITHI, ANN, BIMAS and other T cell epitope prediction software predictions, select and synthesize multiple 9 peptides that may induce the body to produce CTL effects. ELISPOT technology was used to evaluate its immunogenicity, and it was identified that it could induce CD8 + CTL 9 peptide epitopes for T cell responses. Epstein-Barr virus (EBV) was used to transform PBMCs of HFRS patients, and EBV-transformed B-LCLs were established, and B-LCLs loaded with all or part of the HLA class I alleles of the corresponding nine peptides were used as antigen-presenting cells. Magnetic bead separation of CD8 + T cells were used as effector cells, and ELISPOT was use...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com